The Column Group

The Column Group accounts for 30 tracked companies with verified cap-table data, 30 of which disclose round sizes totalling $5.2B. The median disclosed raise is $137M, and the largest is ORIC Pharmaceuticals at $900M, ahead of Kallyope ($487M) and Hexagon Bio ($323M).

The names that recur most often on these portfolio cap tables are The Column Group (30 companies), Euclidean Capital (6 companies), Lux Capital (5 companies), Atlas Venture (5 companies), Foresite Capital (5 companies), Vida Ventures (4 companies). By latest disclosed round, the market skews Series A (16), Series C (5), Series B (3), Grant (2).

• Companies tracked: 30
• Disclosed funding total: $5.2B across 30 companies
• Median disclosed raise: $137M
• Largest raise: ORIC Pharmaceuticals — $900M
• Stage mix: Series A 16 · Series C 5 · Series B 3 · Grant 2
• Most recent dated round: 2026-04-21

Best funded The Column Group companies

1. ORIC Pharmaceuticals — $900M (latest: IPO)
2. Kallyope — $487M (latest: Grant)
3. Hexagon Bio — $323M (latest: Series B)
4. NGM Bio Holdings — $257M (latest: Series A)
5. Escient Pharmaceuticals — $238M (latest: Series C)
6. Remix Therapeutics — $211M (latest: Growth)
7. Kinnate Biopharma — $195M (latest: Series C)
8. Atavistik Bio — $180M (latest: Series A)
9. Accent Therapeutics — $178M (latest: Series C)
10. Casma Therapeutics — $162M (latest: Grant)
11. Gritstone Oncology — $157M (latest: Series A)
12. Selecta Biosciences — $151M (latest: Series E)
13. Eikon Therapeutics — $148M (latest: Series A)
14. Nura Bio — $141M (latest: Series A)
15. OpenStore — $137M (latest: Series B)

The Column Group — related firms and companies (56)

• ORIC Pharmaceuticals
• Kallyope
• Hexagon Bio
• NGM Bio Holdings
• Escient Pharmaceuticals
• Remix Therapeutics
• Kinnate Biopharma
• Atavistik Bio
• Neurona Therapeutics
• Investors like Forerunner
• Kenai Therapeutics
• Investors like Foundation Capital
• Kimia Therapeutics
• Investors like Elemental Impact
• Investors like Google Ventures
• Selecta Biosciences
• Investors like Notable Capital
• Nurix
• Investors like Maven Ventures
• Cajal Neuroscience
• Investors like Battery Ventures
• Surrozen
• Investors like Lux Capital
• Investors like Khosla Ventures
• Eikon Therapeutics
• Investors like Meritech Capital Partners
• Tortugas Neuroscience
• Investors like Primary Venture Partners
• InduPro
• Investors like General Catalyst
• The Column Group co-investors 2026
• Investors like Polaris Partners
• Investors like GIC
• Nura Bio
• Investors like Initialized Capital
• Gritstone bio
• Investors like Foundry Group
• Tr1x
• Investors like Expansion Venture Capital
• Investors like The Column Group
• Accent Therapeutics
• Investors like QED Investors
• OpenStore
• Investors like Felicis
• NILO Therapeutics
• Investors like International Finance Corporation
• Velia
• Investors like Lightbank
• Companies backed by The Column Group
• Casma Therapeutics
• Investors like Script Capital
• A2 Biotherapeutics
• Investors like Founders Fund
• Judo Bio
• Investors like Sapphire Ventures
• Carmot Therapeutics

The Column Group alternatives · All research reports